home / stock / tenx / tenx news


TENX News and Press, Tenax Therapeutics Inc. From 08/17/21

Stock Information

Company Name: Tenax Therapeutics Inc.
Stock Symbol: TENX
Market: NASDAQ
Website: tenaxthera.com

Menu

TENX TENX Quote TENX Short TENX News TENX Articles TENX Message Board
Get TENX Alerts

News, Short Squeeze, Breakout and More Instantly...

TENX - Tenax Therapeutics reports Q2 results

Tenax Therapeutics (NASDAQ:TENX): Q2 GAAP EPS of -$0.10. Revenue of $2.2M Press Release For further details see: Tenax Therapeutics reports Q2 results

TENX - Tenax Therapeutics Reports Second Quarter 2021 Results and Provides Business Update

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today reported financial results for the second quarter of 2021 an...

TENX - Tenax Announces New Publication Highlighting Novel Levosimendan Mechanism of Action in Pulmonary Hypertension Patients with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

Levosimendan was shown to Reduce Stressed Blood Volume (SBV), a Novel and Highly Relevant Mechanism of Action for PH-HFpEF Patients Stressed Blood Volume Reductions Accompany Previously Reported Improvements in Important Cardiovascular Hemodynamic Measurements Reduct...

TENX - Tenax Therapeutics Announced KOL Webinar on Levosimendan for Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

Event to Focus on Current Treatment Landscape and Therapeutic Potential of Levosimendan in PH-HFpEF Monday, August 16th @ 10AM ET Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing produc...

TENX - Tenax Therapeutics reports retirement of CEO and $10M PIPE financing

Tenax Therapeutics (TENX) announces that effective July 13, 2021, Mr. Anthony A. DiTonno will retire as Chief Executive Officer ((CEO)) and Director of the Company, following a successful decade of service with the Company.The Board has appointed Mr. Christopher T. Giordano to serve as CEO an...

TENX - Tenax Therapeutics Announces CEO Transition and $10 Million PIPE Offering Priced At-the-Market under Nasdaq Rules

– Anthony DiTonno Retires from Tenax; Christopher Giordano Appointed as CEO – Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company that address cardiovascular and pulmonary diseases with high unmet medical need, today announced a CEO tran...

TENX - Healthcare names dominate premarket gainers

SeaChange International (SEAC) +26% on insider buying.ReTo Eco-Solutions (RETO) +21% after announcing new iron tailings project.Achieve Life Sciences (ACHV) +17%.Jiuzi Holdings, Inc. (JZXN) +15%.Tiziana Life Sciences PLC (TLSA) +11% on agreement with FHI Clinical to conduct Pha...

TENX - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, traders! We’re starting off the day with a look at the biggest pre-market stock market movers for Wednesday. That includes those that are seeing the largest gains and losses in early morning trading. ...

TENX - Tenax therapeutics to join Russell Microcap

Tenax Therapeutics (TENX) to join the Russell Microcap Index at the conclusion of the 2021 Russell indexes annual reconstitution effect after the U.S. market opens on June 28.“Our inclusion in the Russell Microcap Index comes at an exciting time for our company, as we expect to advance...

TENX - Tenax Therapeutics Set to Join Russell Microcap® Index

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, is set to join the Russell Microcap® Index at the conclusion ...

Previous 10 Next 10